Bionano Genomics Inc (BNGO)

NASDAQ

$1.13

Bionano Genomics, Inc. is a life science instrumentation company in the genome analysis space. The company is headquartered in San Diego, California.

Sector:

Industry:

68 analysts

Strong Buy

Target: $5 (+344.44%)

Market Cap

$13M

P/B Ratio

0.35

Revenue 5Y CAGR

+22.23%

Beta (5Y)

0.66

Adjust inflation

Log

Valuation

Market Cap$13M

P/S0.47

P/B0.35

Profitability

Total Revenue (TTM)$29M

Gross Profit (TTM)$13M

EBITDA-$23M

Profit Margin-109.9%

Operating Margin-118.1%

EPS-$4.10

Growth & Risk

EPS 5Y CAGR-43.44%

Revenue 5Y CAGR+22.23%

FCF 5Y CAGR-15.28%

Beta (5Y)0.66

Sharpe Ratio-0.97